C
Kiniksa Pharmaceuticals International, plc KNSA
$31.98 $1.725.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 17.83M 8.54M -8.89M -12.69M -3.91M
Total Depreciation and Amortization 358.00K 345.00K 400.00K 399.00K 430.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 11.57M 11.84M 6.72M 4.45M 18.56M
Change in Net Operating Assets -1.67M 1.60M 20.54M 5.60M -9.91M
Cash from Operations 28.09M 22.32M 18.77M -2.24M 5.17M
Capital Expenditure -165.00K -99.00K -193.00K 0.00 0.00
Sale of Property, Plant, and Equipment -- -- 0.00 0.00 25.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -3.72M -51.44M 65.49M -6.35M -46.82M
Cash from Investing -3.88M -51.54M 65.29M -6.35M -46.80M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 12.75M 3.18M 2.72M 9.40M 1.14M
Repurchase of Common Stock -2.05M -412.00K -578.00K -2.71M -1.31M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 10.70M 2.77M 2.14M 6.69M -178.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 34.91M -26.45M 86.21M -1.90M -41.81M